Where is the next SARS-CoV-2 variant of concern?
作者信息
Dennehy John J, Gupta Ravindra K, Hanage William P, Johnson Marc C, Peacock Thomas P
机构信息
Biology Department, Queens College, City University of New York, New York, NY 11367, USA; The Graduate Center, City University of New York, New York, NY 11367, USA.
Department of Medicine, University of Cambridge, Cambridge, UK.
出版信息
Lancet. 2022 May 21;399(10339):1938-1939. doi: 10.1016/S0140-6736(22)00743-7.
Abstract
摘要
相似文献
1
Where is the next SARS-CoV-2 variant of concern?下一个值得关注的新冠病毒变异株会出现在哪里？
Lancet. 2022 May 21;399(10339):1938-1939. doi: 10.1016/S0140-6736(22)00743-7.
2
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic.值得关注的新冠病毒Delta变异株AY亚系中的刺突蛋白突变：对疫情未来的影响
Future Microbiol. 2022 Mar;17:219-221. doi: 10.2217/fmb-2021-0286. Epub 2022 Feb 15.
3
Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.实时 RT-PCR 等位基因鉴别检测法用于检测与关注变异株 B.1.1.7 相关的 SARS-CoV-2 刺突蛋白 N501Y 突变。
Microbiol Spectr. 2022 Feb 23;10(1):e0068121. doi: 10.1128/spectrum.00681-21. Epub 2022 Feb 16.
4
Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.新型冠状病毒刺突蛋白G614变体在冷藏后的稳定性超过D614变体。
mSphere. 2021 Mar 31;6(2):e00104-21. doi: 10.1128/mSphere.00104-21.
5
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.阿尔法变异株的刺突糖蛋白中的 P681H 突变逃避了 IFITM 的限制，并且是 I 型干扰素抵抗所必需的。
J Virol. 2022 Dec 14;96(23):e0125022. doi: 10.1128/jvi.01250-22. Epub 2022 Nov 9.
6
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal.葡萄牙出现大量 SARS-CoV-2 刺突 Y839 变异株。
Emerg Microbes Infect. 2020 Dec;9(1):2488-2496. doi: 10.1080/22221751.2020.1844552.
7
New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.2023 年 3 月至 5 月，肯尼亚基利菲出现携带刺突蛋白突变 Y451H 的新型 SARS-CoV-2 奥密克戎变体。
Emerg Infect Dis. 2023 Nov;29(11):2376-2379. doi: 10.3201/eid2911.230894. Epub 2023 Sep 14.
8
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变异株奥密克戎的免疫逃逸能力增强。
Cell Mol Immunol. 2022 Feb;19(2):293-295. doi: 10.1038/s41423-021-00836-z. Epub 2022 Jan 11.
9
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.意大利伦巴第北部 L452R 阳性 SARS-CoV-2 奥密克戎变异株的扩展。
Emerg Infect Dis. 2022 Jun;28(6):1301-1302. doi: 10.3201/eid2806.220210. Epub 2022 Apr 13.
10
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.常见突变对 SARS-CoV-2 刺突 RBD 及其配体人 ACE2 受体结合亲和力和动力学的影响。
Elife. 2021 Aug 26;10:e70658. doi: 10.7554/eLife.70658.
引用本文的文献
1
Diverse patterns of intra-host genetic diversity in chronically infected SARS-CoV-2 patients.慢性感染的新冠病毒患者体内宿主基因多样性的不同模式
Virus Evol. 2025 Jun 15;11(1):veaf047. doi: 10.1093/ve/veaf047. eCollection 2025.
2
Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice.新型冠状病毒刺突蛋白疫苗 S1 亚单位佐剂可改善小鼠的抗体和 T 细胞应答及替代中和作用。
Sci Rep. 2024 Nov 28;14(1):29609. doi: 10.1038/s41598-024-80636-3.
3
SARS-CoV-2 N protein coordinates viral particle assembly through multiple domains.SARS-CoV-2 N 蛋白通过多个结构域协调病毒粒子组装。
J Virol. 2024 Nov 19;98(11):e0103624. doi: 10.1128/jvi.01036-24. Epub 2024 Oct 16.
4
Factors Associated with Prolonged SARS-CoV-2 Viral Positivity in an Italian Cohort of Hospitalized Patients.意大利住院患者队列中与新冠病毒长期阳性相关的因素
Diseases. 2024 Jun 28;12(7):138. doi: 10.3390/diseases12070138.
5
Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution.阳性选择是 SARS-CoV-2 进化中重复敲除 ORF8 的基础。
Nat Commun. 2024 Apr 13;15(1):3207. doi: 10.1038/s41467-024-47599-5.
6
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.大型社区监测研究中 SARS-CoV-2 的持续流行率。
Nature. 2024 Feb;626(8001):1094-1101. doi: 10.1038/s41586-024-07029-4. Epub 2024 Feb 21.
7
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections.利用大测序数据识别慢性严重急性呼吸系统综合征冠状病毒 2 感染。
Nat Commun. 2024 Jan 20;15(1):648. doi: 10.1038/s41467-024-44803-4.
8
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.疫苗诱导的SARS-CoV-2特异性中和抗体和T细胞在保护和疾病中的不同作用。
Mol Ther. 2024 Feb 7;32(2):540-555. doi: 10.1016/j.ymthe.2024.01.007. Epub 2024 Jan 11.
9
Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking.SARS-CoV-2 基因组数据库、注释、分析和变异跟踪的网络资源。
Viruses. 2023 May 12;15(5):1158. doi: 10.3390/v15051158.
10
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
本文引用的文献
1
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.英国新冠病毒B.1.1.7谱系的起源与分子进化
Virus Evol. 2022 Aug 26;8(2):veac080. doi: 10.1093/ve/veac080. eCollection 2022.
2
Recurrent SARS-CoV-2 mutations in immunodeficient patients.免疫缺陷患者中出现的新冠病毒（SARS-CoV-2）复发性突变
Virus Evol. 2022 Aug 11;8(2):veac050. doi: 10.1093/ve/veac050. eCollection 2022 Jul.
3
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use.使用索托维单抗后新冠病毒德尔塔变异株中的耐药突变
N Engl J Med. 2022 Apr 14;386(15):1477-1479. doi: 10.1056/NEJMc2120219. Epub 2022 Mar 9.
4
Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials.持续性严重急性呼吸综合征冠状病毒2感染：急需获得治疗和开展试验。
Lancet Infect Dis. 2021 Oct;21(10):1345-1347. doi: 10.1016/S1473-3099(21)00464-3. Epub 2021 Aug 16.
5
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
Zotero 插件